Why Clover Health (CLOV) Keeps On Disappointing?


The CLOV stock price fluctuated between $7.92 and $8.51 throughout the trading session with the volume trading being 19M shares, which represented a negative variation when compared to the three months average volume of 55M shares.

The share price of Clover Health Investments, Corp. (NasdaqGS:CLOV) ran up 1.86% to close Monday’s market session at $8.2, higher as compared to yesterday’s close which brings the market valuation of the company to $3.35B.

The 52-week high for the Clover Health Investments, Corp.’s shares is $28.85. That puts it -71.58% from that peak but still a -27.28% gain since the share price dropped to a 52-week low of $6.31, while the S&P 500’s share price change was of 36.19%.


What does the trading volume tell us about the CLOV stock?

During the last trading session, Clover Health Investments, Corp. (NasdaqGS:CLOV) has seen growth in its daily volume. The daily volume was of 55M, while in the last 10 days the average was 27.46M and last three months – 55.4M.
The increasing interest in the CLOV stock from the investors is helping to drive the stock price up.

Shrinking short interest

The Clover Health Investments, Corp.’s shares are seeing a decreasing short interest compared to the previous month. As of today, there are 35.89M shares being shorted which translates into 0.31 of a short ratio for CLOV, while in the previous month the shorted shares were 41.27M.

Clover Health Investments, Corp. (NasdaqGS:CLOV) financials

With a market cap of 3.35B, Clover Health Investments, Corp. holds a total cash of $684.57M that translates into $1.68 per share, while the total debt is of $55.94M.

The company has seen a decrease in the revenue with a year-over-year quarterly revenue growth percentage of 18.00%. The current revenue is of $720.55M that is $6.27 per share.